NewAmsterdam Pharma Company Forecast, price target & analysts
$24.70
1.20%
yesterday
Nasdaq,
Aug 25, 10:15 pm CET
Industry
NewAmsterdam Pharma Company Target price 2025 - Analyst rating & recommendation
Powered by
NewAmsterdam Pharma Company Classifications & Recommendation:
Buy
90%
Hold
10%
NewAmsterdam Pharma Company Price Target
| Target Price | $43.86 |
| Price | $25.00 |
| Potential |
75.44%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target NewAmsterdam Pharma Company 2026 .
The average NewAmsterdam Pharma Company target price is $43.86.
This is
75.44%
register free of charge
$54.60
118.40%
register free of charge
$27.27
9.08%
register free of charge
|
|
| A rating was issued by 20 analysts: 18 Analysts recommend NewAmsterdam Pharma Company to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the NewAmsterdam Pharma Company stock has an average upside potential 2026 of
75.44%
register free of charge
|
Earnings per share, P/E ratio and EV/sales Estimates 2023, 2024 to 2032
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '22 |
2023 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.95 | -2.21 |
| 495.83% | 132.63% | |
| P/E | negative | |
| EV/Sales | 183.51 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
